These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 25757942
1. Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case-control study. Doulgere J, Otto B, Nassour M, Wolters-Eisfeld G, Rohde H, Magnus T, Wagener C, Streichert T. BMJ Open; 2015 Mar 10; 5(3):e005659. PubMed ID: 25757942 [Abstract] [Full Text] [Related]
2. Serum neutrophil gelatinase-associated lipocalin (NGAL) in patients with Shiga toxin mediated haemolytic uraemic syndrome (STEC-HUS). Lukasz A, Beneke J, Menne J, Vetter F, Schmidt BM, Schiffer M, Haller H, Kümpers P, Kielstein JT. Thromb Haemost; 2014 Feb 10; 111(2):365-72. PubMed ID: 24172823 [Abstract] [Full Text] [Related]
3. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection. Bruyand M, Mariani-Kurkdjian P, Gouali M, de Valk H, King LA, Le Hello S, Bonacorsi S, Loirat C. Med Mal Infect; 2018 May 10; 48(3):167-174. PubMed ID: 29054297 [Abstract] [Full Text] [Related]
4. Desperately seeking diarrhoea: outbreak of haemolytic uraemic syndrome caused by emerging sorbitol-fermenting shiga toxin-producing Escherichia coli O157:H-, Germany, 2009. Nielsen S, Frank C, Fruth A, Spode A, Prager R, Graff A, Plenge-Bönig A, Loos S, Lütgehetmann M, Kemper MJ, Müller-Wiefel DE, Werber D. Zoonoses Public Health; 2011 Dec 10; 58(8):567-72. PubMed ID: 21824358 [Abstract] [Full Text] [Related]
5. Estimating true incidence of O157 and non-O157 Shiga toxin-producing Escherichia coli illness in Germany based on notification data of haemolytic uraemic syndrome. Kuehne A, Bouwknegt M, Havelaar A, Gilsdorf A, Hoyer P, Stark K, Werber D, HUS active surveillance network Germany. Epidemiol Infect; 2016 Nov 10; 144(15):3305-3315. PubMed ID: 27468812 [Abstract] [Full Text] [Related]
6. Antibody response to lipopolysaccharides and recombinant proteins of Shiga toxin (STX)-producing Escherichia coli (STEC) in children with haemolytic uraemic syndrome in Poland. Rastawicki W, Śmietańska K, Rokosz-Chudziak N, Wołkowicz T. Lett Appl Microbiol; 2020 Jun 10; 70(6):440-446. PubMed ID: 32270510 [Abstract] [Full Text] [Related]
7. Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing Escherichia coli, an overview of 10 years of surveillance in France, 2007 to 2016. Bruyand M, Mariani-Kurkdjian P, Le Hello S, King LA, Van Cauteren D, Lefevre S, Gouali M, Jourdan-da Silva N, Mailles A, Donguy MP, Loukiadis E, Sergentet-Thevenot D, Loirat C, Bonacorsi S, Weill FX, De Valk H, Réseau français hospitalier de surveillance du SHU pédiatriqueMembers of the Réseau français hospitalier de surveillance du SHU pédiatrique have been listed at the end of the article.. Euro Surveill; 2019 Feb 10; 24(8):. PubMed ID: 30808442 [Abstract] [Full Text] [Related]
8. Risk of haemolytic uraemic syndrome caused by shiga-toxin-producing Escherichia coli infection in adult women in Japan. Fujii J, Mizoue T, Kita T, Kishimoto H, Joh K, Nakada Y, Ugajin S, Naya Y, Nakamura T, Tada Y, Okabe N, Maruyama Y, Saitoh K, Kurozawa Y. Epidemiol Infect; 2016 Apr 10; 144(5):952-61. PubMed ID: 26470913 [Abstract] [Full Text] [Related]
9. Community-wide outbreak of haemolytic uraemic syndrome associated with Shiga toxin 2-producing Escherichia coli O26:H11 in southern Italy, summer 2013. Germinario C, Caprioli A, Giordano M, Chironna M, Gallone MS, Tafuri S, Minelli F, Maugliani A, Michelacci V, Santangelo L, Mongelli O, Montagna C, Scavia G, all participants of the Outbreak investigation team. Euro Surveill; 2016 Sep 22; 21(38):. PubMed ID: 27684204 [Abstract] [Full Text] [Related]
10. Ongoing haemolytic uraemic syndrome (HUS) outbreak caused by sorbitol-fermenting (SF) Shiga toxin-producing Escherichia coli (STEC) O157, Germany, December 2016 to May 2017. Vygen-Bonnet S, Rosner B, Wilking H, Fruth A, Prager R, Kossow A, Lang C, Simon S, Seidel J, Faber M, Schielke A, Michaelis K, Holzer A, Kamphausen R, Kalhöfer D, Thole S, Mellmann A, Flieger A, Stark K. Euro Surveill; 2017 May 25; 22(21):. PubMed ID: 28597831 [Abstract] [Full Text] [Related]
11. Bloody Diarrhea and Shiga Toxin-Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network. Ardissino G, Vignati C, Masia C, Capone V, Colombo R, Tel F, Daprai L, Testa S, Dodaro A, Paglialonga F, Luini M, Brigotti M, Picicco D, Baldioli C, Pagani F, Ceruti R, Tommasi P, Possenti I, Cresseri D, Consonni D, Montini G, Arghittu M, ItalKid-HUS Network. J Pediatr; 2021 Oct 25; 237():34-40.e1. PubMed ID: 34197890 [Abstract] [Full Text] [Related]
12. Unusual severe case of hemolytic uremic syndrome due to Shiga toxin 2d-producing E. coli O80:H2. Wijnsma KL, Schijvens AM, Rossen JWA, Kooistra-Smid AMDM, Schreuder MF, van de Kar NCAJ. Pediatr Nephrol; 2017 Jul 25; 32(7):1263-1268. PubMed ID: 28343354 [Abstract] [Full Text] [Related]
13. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli. Mody RK, Luna-Gierke RE, Jones TF, Comstock N, Hurd S, Scheftel J, Lathrop S, Smith G, Palmer A, Strockbine N, Talkington D, Mahon BE, Hoekstra RM, Griffin PM. Arch Pediatr Adolesc Med; 2012 Oct 25; 166(10):902-9. PubMed ID: 22869280 [Abstract] [Full Text] [Related]
14. Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab. Delmas Y, Vendrely B, Clouzeau B, Bachir H, Bui HN, Lacraz A, Hélou S, Bordes C, Reffet A, Llanas B, Skopinski S, Rolland P, Gruson D, Combe C. Nephrol Dial Transplant; 2014 Mar 25; 29(3):565-72. PubMed ID: 24293658 [Abstract] [Full Text] [Related]
15. Decreased severity of Shiga toxin-producing Escherichia coli haemolytic uraemic syndrome (STEC-HUS) in a child with type 1 von Willebrand disease. Geramita MA, Hofer J, Cooper J, Moritz ML. BMJ Case Rep; 2017 Aug 30; 2017():. PubMed ID: 28855217 [Abstract] [Full Text] [Related]
16. A practical composite risk score for the development of Haemolytic Uraemic Syndrome from Shiga toxin-producing Escherichia coli. Hamilton D, Cullinan J. Eur J Public Health; 2019 Oct 01; 29(5):861-868. PubMed ID: 31326985 [Abstract] [Full Text] [Related]
17. Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry. Kielstein JT, Beutel G, Fleig S, Steinhoff J, Meyer TN, Hafer C, Kuhlmann U, Bramstedt J, Panzer U, Vischedyk M, Busch V, Ries W, Mitzner S, Mees S, Stracke S, Nürnberger J, Gerke P, Wiesner M, Sucke B, Abu-Tair M, Kribben A, Klause N, Schindler R, Merkel F, Schnatter S, Dorresteijn EM, Samuelsson O, Brunkhorst R, Collaborators of the DGfN STEC-HUS registry. Nephrol Dial Transplant; 2012 Oct 01; 27(10):3807-15. PubMed ID: 23114903 [Abstract] [Full Text] [Related]
18. Characterization of Shiga-toxigenic Escherichia coli isolated from cases of diarrhoea & haemolytic uremic syndrome in north India. Kumar A, Taneja N, Bharti B, Sharma M. Indian J Med Res; 2014 Dec 01; 140(6):778-84. PubMed ID: 25758577 [Abstract] [Full Text] [Related]
19. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values. López EL, Contrini MM, Glatstein E, Ayala SG, Santoro R, Ezcurra G, Teplitz E, Matsumoto Y, Sato H, Sakai K, Katsuura Y, Hoshide S, Morita T, Harning R, Brookman S. Pediatr Infect Dis J; 2012 Jan 01; 31(1):20-4. PubMed ID: 21829137 [Abstract] [Full Text] [Related]
20. Microparticle generation and leucocyte death in Shiga toxin-mediated HUS. Ge S, Hertel B, Emden SH, Beneke J, Menne J, Haller H, von Vietinghoff S. Nephrol Dial Transplant; 2012 Jul 01; 27(7):2768-75. PubMed ID: 22234918 [Abstract] [Full Text] [Related] Page: [Next] [New Search]